POLYMORPHIC FORM OF [5-FLUORINE-3-({ 2-[(4-FLUOROBENZENE) SULFONYL]PYRIDINE-3-YL} METHYL)-2-METHYLINDOLE-1-YL]-ACETIC ACID Russian patent published in 2021 - IPC C07D401/06 A61K31/4439 A61P31/00 

Abstract RU 2751319 C2

FIELD: chemistry.

SUBSTANCE: present invention relates to a method for producing a polymorphic form of [5-fluorine-3-({2-[(4-fluorobenzene)sulfonyl]pyridine-3-yl}methyl)-2-methylindole-1-yl]-acetic acids. Method for producing the polymorphic form 2 of [5-fluorine-3-({2-[(4-fluorobenzene)sulfonyl]pyridine-3-yl}methyl)-2-methylindole-1-yl]acetic acid (compound 1) is characterized by Raman spectrum with Fourier transformation with characteristic peaks at 3063 ± 2 cm-1, 1578 ± 2 cm-1, 1423 ± 2 cm-1, 1209 ± 2 cm-1, 1187 ± 2 cm-1, 1166 ± 2 cm-1, 1150 ± 2 cm-1, 930 ± 2 cm-1, 883 ± 2 cm-1, 770 ± 2 cm-1, 356 ± 2 cm-1, 304 ± 2 cm-1, 167 ± 2 cm-1, 119 ± 2 cm-1 or the following crystal lattice parameters:

a 10.8 ± 0.1 Å b 13.9 ± 0.1 Å c 7.8 ± 0.1 Å α 101 ± 1° β 110 ± 1° γ 79 ± 1° cell volume 1.068 Å3 RP 4.9% weighted RP 7.1%

The method is carried out by (a) suspending compound 1 in a solvent containing acetonitrile, a mixture of acetonitrile and water or a ketone solvent selected from methyl isobutyl ketone, methyl ethyl ketone and mixtures thereof, wherein compound 1 is in an amorphous form, in a crystalline form other than polymorphic form 2, or in the form of a mixture of polymorphic form 2 with one or more other polymorphic forms; (b) mixing the suspension at a temperature of about 15 to 25 °C for 15 to 30 days; and (c) separating and drying the solid [5-fluorine-3-({2-[(4-fluorobenzene)sulfonyl]pyridine-3-yl}methyl)-2-methylindole-1-yl]acetic acid. The invention also relates to a method for producing a polymorphic form of 2 [5-fluorine-3-({2-[(4-fluorobenzene)sulfonyl]pyridine-3-yl}methyl)-2-methylindole-1-yl]acetic acid (compound 1) by obtaining a saturated solution of compound 1 in a solvent selected from acetonitrile, acetonitrile and water or a ketone solvent selected from methyl isobutyl ketone, methyl ethyl ketone or a mixture thereof; seeding the specified saturated solution with crystals of the polymorphic form 2 of compound 1; holding with crystallization; and separating crystals of polymorphic form 2 of compound 1.

EFFECT: production of a thermodynamically stable polymorphic form of 2 [5-fluorine-3-({2-[(4-fluorobenzene)sulfonyl]pyridine-3-yl}methyl)-2-methylindole-1-yl]acetic acid.

6 cl, 18 dwg, 3 tbl, 9 ex

Similar patents RU2751319C2

Title Year Author Number
POLYMORPHOUS FORM OF [5-FLUORO-3-({2-[(4-FLUOROBENZENE) SULPHONYL]PYRIDIN-3-YL}METHYL)-2-METHYLINDOLE-1-YL]-ACETIC ACID 2015
  • Khilfiker Rolf
  • Grosse-Sender Katya
RU2702343C2
METHOD OF PRODUCING 3-SUBSTITUTED (INDOL-1-YL)-ACETIC ACID ESTERS 2014
  • Tonnel Zhak
  • Blanshe Silvi
  • Deval Gijom Leonard Per
RU2676332C1
COMPOUNDS HAVING CRTH2 ANTAGONIST ACTIVITY 2009
  • Armer Richard Ehdvard
  • Pettifer Ehrik Roj
  • Vittaker Mark
  • Vajn Grekham Majkl
  • Vajl Dzhulija
  • Shroer Frehnk
RU2503672C2
AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYLINDOL-1-YL)-ACETIC ACID 2012
  • Betankur Ajmester
  • Lemyu Mark
  • Tibert Rosh
RU2616000C2
POLYMORPHS OF 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE, METHODS OF PRODUCTION AND PHARMACEUTICAL USES THEREOF 2014
  • Stalts Dzheffri
RU2658009C2
CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE, SUITABLE FOR TREATMENT OF ABNORMAL GROWTH OF CELLS IN MAMMALS 2008
  • Kehmpeta Ehntoni Majkl
  • Chekal Brajan Patrik
  • Maklaflin Robert Uill'Jam
  • Singer Robert Alan
RU2518898C2
POLYMORPHIC MODIFICATIONS OF N-[(3-FLUORO-4-METHOXYPYRIDINE-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({ 4-[(2-OXOPYRIDINE-1-YL)METHYL]PHENYL} METHYL)PYRAZOLE-4-CARBOXAMIDE AND THEIR SALTS 2017
  • Beaton, Haydn
  • Crowe, David Malcolm
  • Edwards, Hannah Joy
  • Griffiths-Haynes, Nicholas James
RU2756273C2
3-(1H-INDOL-3-YL)-4-[2-(4-METHYLPIPERAZIN-1-YL)QUINAZOLIN-4-YL]PYRROLE-2,5-DIONE SALTS 2008
  • Karpinski P'Otr
  • Papoutsakis Dimitris
  • Jouehll Gaj
RU2487128C2
4-METHYL-N-[3-4-METHYLIMIDAZOL-1-YL)-5-TRIFLUOROMETHYLPHENYL]-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)BENZAMIDE SALTS 2006
  • Manli Pol U.
  • Shi Vehn'Chun
  • Satton Pol Allen
  • Karpinski Petr Kh.
  • Vu Rain
  • Monn'E Stefani
  • Brotsio Jerg
RU2509767C1
SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS AND USE 2012
  • Myuller Dzhordzh V.
  • Man Khon-Vakh
  • Koen Bendzhamin M.
  • Li In
  • Syuj Dzhin
  • Leong Uillyam V.
RU2611007C2

RU 2 751 319 C2

Authors

Grosse-Sender Katya

Khilfiker Rolf

Dates

2021-07-13Published

2015-05-01Filed